NCT03974139View on ClinicalTrials.gov

Impact of Metformin on Leptin Transport in Cerebrospinal Fluid of Obese Patients

PHASE2RecruitingINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

June 15, 2024

Study Completion Date

September 30, 2024

Conditions
Obesity Without Type 2 Diabetes, With BMI>30
Interventions
DRUG

Metformin Oral Tablet

Day 1 to day 3: 500 mg/day Day 4 to day 6: 500 mg/twice a day Day 7 to day 9: 500 mg three times a day Day 10 until next lumbar puncture : 850 mg three times a day

Trial Locations (1)

62022

RECRUITING

Centre hospitalier d'Arras, Arras

All Listed Sponsors
collaborator

Centre Hospitalier Arras

OTHER

lead

Lille Catholic University

OTHER